FDA Emphasizes Process Integrity In Questioning Approval Of Knee Device
Executive Summary
Drug sponsors trying to gauge how FDA's new leadership might handle controversies surrounding their NDAs received some sobering insight when the agency released its internal assessment of the approval of ReGen Biologics' Menaflex knee repair device.